Research Analysts’ Weekly Ratings Updates for Veeva Systems (VEEV)

Veeva Systems (NYSE: VEEV) recently received a number of ratings updates from brokerages and research firms:

• 3/6/2025 – Veeva Systems had its price target raised by analysts at Morgan Stanley from $195.00 to $201.00. They now have an “underweight” rating on the stock.
• 3/6/2025 – Veeva Systems had its price target raised by analysts at Scotiabank from $240.00 to $245.00. They now have a “sector perform” rating on the stock.
• 3/6/2025 – Veeva Systems had its “overweight” rating reaffirmed by analysts at Stephens. They now have a $280.00 price target on the stock.
• 3/6/2025 – Veeva Systems had its price target raised by analysts at Robert W. Baird from $283.00 to $285.00. They now have an “outperform” rating on the stock.
• 3/6/2025 – Veeva Systems had its price target raised by analysts at Truist Financial Co. from $210.00 to $217.00. They now have a “hold” rating on the stock.
• 3/6/2025 – Veeva Systems had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $270.00 price target on the stock.
• 2/17/2025 – Veeva Systems was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 2/6/2025 – Veeva Systems was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 1/23/2025 – Veeva Systems was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “sell” rating. They now have a $200.00 price target on the stock, down previously from $261.00.
• 1/23/2025 – Veeva Systems was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 1/17/2025 – Veeva Systems had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $270.00 price target on the stock.

Veeva Systems Stock Up 1.5 %

Shares of NYSE:VEEV traded up $3.59 during trading on Monday, hitting $237.65. The stock had a trading volume of 426,259 shares, compared to its average volume of 1,191,052. The stock has a 50-day simple moving average of $227.12 and a two-hundred day simple moving average of $221.55. The stock has a market capitalization of $38.58 billion, a price-to-earnings ratio of 58.68, a price-to-earnings-growth ratio of 1.89 and a beta of 0.88. Veeva Systems Inc. has a 12-month low of $170.25 and a 12-month high of $258.93.

Hedge Funds Weigh In On Veeva Systems

Several institutional investors and hedge funds have recently modified their holdings of VEEV. T. Rowe Price Investment Management Inc. increased its stake in shares of Veeva Systems by 3.5% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 5,169,698 shares of the technology company’s stock valued at $1,086,930,000 after purchasing an additional 177,201 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Veeva Systems by 64.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,545,451 shares of the technology company’s stock worth $744,084,000 after purchasing an additional 1,392,256 shares during the last quarter. State Street Corp raised its holdings in shares of Veeva Systems by 1.5% during the third quarter. State Street Corp now owns 3,293,141 shares of the technology company’s stock valued at $691,132,000 after acquiring an additional 47,872 shares during the last quarter. Leigh Baldwin & CO. LLC purchased a new position in shares of Veeva Systems in the fourth quarter valued at approximately $685,355,000. Finally, FMR LLC boosted its stake in shares of Veeva Systems by 7.8% in the fourth quarter. FMR LLC now owns 3,213,360 shares of the technology company’s stock worth $675,609,000 after acquiring an additional 232,116 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.